DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by Pacer Advisors Inc.

Pacer Advisors Inc. boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 116.6% during the second quarter, Holdings Channel.com reports. The institutional investor owned 31,160 shares of the medical instruments supplier’s stock after acquiring an additional 16,776 shares during the period. Pacer Advisors Inc.’s holdings in DENTSPLY SIRONA were worth $776,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of XRAY. 9258 Wealth Management LLC purchased a new stake in shares of DENTSPLY SIRONA in the fourth quarter valued at $203,000. US Bancorp DE boosted its stake in shares of DENTSPLY SIRONA by 3.1% during the 4th quarter. US Bancorp DE now owns 50,307 shares of the medical instruments supplier’s stock worth $1,790,000 after purchasing an additional 1,490 shares during the last quarter. TD Asset Management Inc grew its holdings in shares of DENTSPLY SIRONA by 37.5% during the fourth quarter. TD Asset Management Inc now owns 545,665 shares of the medical instruments supplier’s stock worth $19,420,000 after buying an additional 148,788 shares in the last quarter. Allianz Asset Management GmbH raised its position in shares of DENTSPLY SIRONA by 103.0% in the fourth quarter. Allianz Asset Management GmbH now owns 363,382 shares of the medical instruments supplier’s stock valued at $12,933,000 after buying an additional 184,334 shares during the last quarter. Finally, Treasurer of the State of North Carolina lifted its stake in shares of DENTSPLY SIRONA by 1.0% during the fourth quarter. Treasurer of the State of North Carolina now owns 93,762 shares of the medical instruments supplier’s stock valued at $3,337,000 after buying an additional 920 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have commented on XRAY shares. Barrington Research reaffirmed an “outperform” rating and issued a $36.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Evercore ISI dropped their target price on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, July 9th. Needham & Company LLC reissued a “buy” rating and issued a $34.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Finally, Stifel Nicolaus cut their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research note on Thursday, July 18th. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $33.22.

View Our Latest Stock Report on DENTSPLY SIRONA

DENTSPLY SIRONA Price Performance

XRAY opened at $27.05 on Friday. The company has a 50 day moving average of $25.54 and a two-hundred day moving average of $27.65. DENTSPLY SIRONA Inc. has a 52-week low of $23.58 and a 52-week high of $37.60. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The company has a market cap of $5.48 billion, a P/E ratio of -61.48, a P/E/G ratio of 1.25 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The company had revenue of $984.00 million during the quarter, compared to analyst estimates of $993.61 million. During the same quarter in the prior year, the company posted $0.51 earnings per share. The firm’s revenue for the quarter was down 4.3% on a year-over-year basis. On average, analysts expect that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 2.37%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio is presently -145.45%.

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Recommended Stories

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.